Congressional Research Service Reports - 12 Matching Results
Search Results
- The SUPPORT for Patients and Communities Act (P.L. 115-271): Food and Drug Administration and Controlled Substance Provisions
- This report summarizes the provisions in Title III--the FDA (Food and Drug Administration) and Controlled Substance Provisions, as well as Section 4004 "Modernizing the Reporting Requirements of Biological and Biosimilar Products" in Title IV--Offsets.
- Drug Crop Eradication and Alternative Development in the Andes
- The United States has supported drug crop eradication and alternative development programs in the Andes for decades. Colombia, Bolivia, and Peru collectively produce nearly the entire global supply of cocaine. In addition, Colombia has become a producer of high quality heroin, most of it destined for the United States and Europe. The United States provides counternarcotics assistance through the Andean Counterdrug Initiative (ACI). The program supports a number of missions, including interdiction of drug trafficking, illicit crop eradication, alternative development, and rule of law and democracy promotion. From FY2000 through FY2005, the United States has provided a total of about $4.3 billion in ACI funds.
- Methamphetamine: Legislation and Issues in the 109th Congress
- Illicit methamphetamine (MA) production and use are longstanding and severe problems in some states. This report provides a brief overview of MA abuse, production, trafficking, and of the federal methamphetamine-specific programs, and legislation that is being actively considered by the 109th Congress. This report will be updated to reflect future legislative activity.
- The Safe and Drug-Free Schools and Communities Act: Reauthorization and Appropriations
- This report discusses the approved reauthorization legislation to extend and amend the Elementary and Secondary Education Act (ESEA) and the Safe and Drug-Free Schools and Communities Act (SDFSCA).
- Mexico's Counter-Narcotics Efforts under Fox, December 2000 to October 2004
- No Description Available.
- Drug Certification Requirements and Proposed Congressional Modifications in 2001
- This report provides a brief summary of the existing drug certification requirements for drug producing and drug-transit countries, background on the experience, criticisms, and reform efforts under these provisions; a summary of early congressional options and proposals advanced in 2001, with possible advantages and disadvantages; a summary of later initiatives with legislative activity; and (5) a tracking of legislative action on the major initiatives.
- Drug Control: International Policy and Options
- Over the past decade, worldwide production of illicit drugs has risen dramatically: opium and marijuana production has roughly doubled and coca production tripled. Street prices of cocaine and heroin have fallen significantly in the past 20 years, reflecting increased availability. Despite apparent national political resolve to deal with the drug problem, inherent contradictions regularly appear between U.S. anti-drug policy and other national policy goals and concerns. The mix of competing domestic and international pressures and priorities has produced an ongoing series of disputes within and between the legislative and executive branches concerning U.S. international drug policy. One contentious issue has been the Congressionally-mandated certification process, an instrument designed to induce specified drug-exporting countries to prioritize or pay more attention to the fight against narcotics businesses.
- Coordination of Federal Efforts to Control Illicit Drug Traffic
- This report discusses how best to coordinate the Federal government's multi-agency efforts to curb illicit traffic in dangerous drugs has once again become an issue of major interest to the Congress. Critics of the Reagan Administration's anti-drug program contend that it lacks an overall strategy and that it suffers from the absence of a central mechanism for the formulation of general policy as well as for the broad direction of operations
- Developments in the Right of Privacy: Whalen v. Roe and the Extent of the Right to Anonymity in the Doctor-Patient Relationship
- This report outlines the question of privacy between doctor and patient and the potential abuse of prescription drugs without state and federal intervention.
- Drug Abuse and Minority Groups in the United States: Selected References
- This bibliography is a collection of published works concerning minority groups and drug abuse in the United States.
- Drug Abuse in the Military: Selected References 1970-1972
- This bibliography collects published works on drug abuse in the United States Military published from 1970 to 1972.
- Methadone Maintenance Treatment for Heroin Addiction
- This report discusses methadone treatment centers for heroin addicts and research regarding their successes and limitations.